AGENAgenus Inc.
$3.03-39% 1Y
$3.03
$2.7752 weeks$9.93
Is the price fair?
What AGEN's price assumes
Agenus Inc. trades at 2.92× earnings against 18.6× for the median Biotechnology name, cheaper than its own group.
2.92
Trailing P/E · Biotechnology median 18.6 · cheaper than the typical name in its group
- Price / sales
- 1.03
Price / sales · as of 2026-Q1
- EV / sales
- 0.99
EV / sales
Details›
- EV / EBITas of 2026-Q1
- 15.0
- EV / salesas of 2026-Q1
- 0.99
- Healthcare median P/E509 names
- 26.0
- Biotechnology median P/E244 names
- 18.6
- Market capitalisation
- $314M
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.